Further, similar to prostate cancer cells and patients, expression of Group IIA sPLA2 was higher in cell lines derived from highly metastatic and aggressive TNBC cells, as compared to non-cancerous (MCF-10A) and non-metastatic cells (BT-474, MCF-7). This evidence concerns the gene PLA2G2A and prostate cancer.